These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
354 related articles for article (PubMed ID: 11745721)
21. Intranasal delivery of zidovudine by PLA and PLA-PEG blend nanoparticles. Mainardes RM; Khalil NM; Gremião MP Int J Pharm; 2010 Aug; 395(1-2):266-71. PubMed ID: 20580792 [TBL] [Abstract][Full Text] [Related]
22. Effective protein release from PEG/PLA nano-particles produced by compressed gas anti-solvent precipitation techniques. Caliceti P; Salmaso S; Elvassore N; Bertucco A J Control Release; 2004 Jan; 94(1):195-205. PubMed ID: 14684283 [TBL] [Abstract][Full Text] [Related]
23. Folate-conjugated amphiphilic hyperbranched block copolymers based on Boltorn H40, poly(L-lactide) and poly(ethylene glycol) for tumor-targeted drug delivery. Prabaharan M; Grailer JJ; Pilla S; Steeber DA; Gong S Biomaterials; 2009 Jun; 30(16):3009-19. PubMed ID: 19250665 [TBL] [Abstract][Full Text] [Related]
24. Comprehensive study of the drug delivery properties of poly(l-lactide)-poly(ethylene glycol) nanoparticles in rats and tumor-bearing mice. Shalgunov V; Zaytseva-Zotova D; Zintchenko A; Levada T; Shilov Y; Andreyev D; Dzhumashev D; Metelkin E; Urusova A; Demin O; McDonnell K; Troiano G; Zale S; Safarovа E J Control Release; 2017 Sep; 261():31-42. PubMed ID: 28611009 [TBL] [Abstract][Full Text] [Related]
25. Methoxy poly(ethylene glycol)-poly(lactide) (MPEG-PLA) nanoparticles for controlled delivery of anticancer drugs. Dong Y; Feng SS Biomaterials; 2004 Jun; 25(14):2843-9. PubMed ID: 14962562 [TBL] [Abstract][Full Text] [Related]
26. Preparation and characterization of biodegradable nanospheres composed of methoxy poly(ethylene glycol) and DL-lactide block copolymer as novel drug carriers. Kim SY; Shin IG; Lee YM J Control Release; 1998 Dec; 56(1-3):197-208. PubMed ID: 9801443 [TBL] [Abstract][Full Text] [Related]
27. Tumor-targeted paclitaxel-loaded folate conjugated poly(ethylene glycol)-poly(L-lactide) microparticles produced by supercritical fluid technology. Huang X; Zhang Y; Yin G; Pu X; Liao X; Huang Z; Chen X; Yao Y J Mater Sci Mater Med; 2015 Feb; 26(2):95. PubMed ID: 25649516 [TBL] [Abstract][Full Text] [Related]
28. Poly(d,l-lactide)/polyethylene glycol micro/nanofiber mats as paclitaxel-eluting carriers: preparation and characterization of fibers, in vitro drug release, antiangiogenic activity and tumor recurrence prevention. Hobzova R; Hampejsova Z; Cerna T; Hrabeta J; Venclikova K; Jedelska J; Bakowsky U; Bosakova Z; Lhotka M; Vaculin S; Franek M; Steinhart M; Kovarova J; Michalek J; Sirc J Mater Sci Eng C Mater Biol Appl; 2019 May; 98():982-993. PubMed ID: 30813105 [TBL] [Abstract][Full Text] [Related]
29. Semi-interpenetrating network of poly(ethylene glycol) and poly(D,L-lactide) for the controlled delivery of protein drugs. Brown CD; Stayton PS; Hoffman AS J Biomater Sci Polym Ed; 2005; 16(2):189-201. PubMed ID: 15794485 [TBL] [Abstract][Full Text] [Related]
30. Development of PEG-PLGA based Intravenous Low Molecular Weight Heparin (LMWH) Nanoparticles Intended to Treat Venous Thrombosis. Jogala S; Rachamalla SS; Aukunuru J Curr Drug Deliv; 2016; 13(5):698-710. PubMed ID: 26777886 [TBL] [Abstract][Full Text] [Related]
31. On the design of in situ forming biodegradable parenteral depot systems based on insulin loaded dialkylaminoalkyl-amine-poly(vinyl alcohol)-g-poly(lactide-co-glycolide) nanoparticles. Packhaeuser CB; Kissel T J Control Release; 2007 Nov; 123(2):131-40. PubMed ID: 17854938 [TBL] [Abstract][Full Text] [Related]
32. Folate-conjugated amphiphilic star-shaped block copolymers as targeted nanocarriers. Zhu J; Zhou Z; Yang C; Kong D; Wan Y; Wang Z J Biomed Mater Res A; 2011 Jun; 97(4):498-508. PubMed ID: 21509931 [TBL] [Abstract][Full Text] [Related]
33. Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles. Sant S; Poulin S; Hildgen P J Biomed Mater Res A; 2008 Dec; 87(4):885-95. PubMed ID: 18228249 [TBL] [Abstract][Full Text] [Related]
34. Particle characteristics and biodistribution of camptothecin-loaded PLA/(PEG-PPG-PEG) nanoparticles. Kunii R; Onishi H; Ueki K; Koyama K; Machida Y Drug Deliv; 2008 Jan; 15(1):3-10. PubMed ID: 18197517 [TBL] [Abstract][Full Text] [Related]
35. Effect of aqueous solubility of grafted moiety on the physicochemical properties of poly(d,l-lactide) (PLA) based nanoparticles. Essa S; Rabanel JM; Hildgen P Int J Pharm; 2010 Mar; 388(1-2):263-73. PubMed ID: 20060450 [TBL] [Abstract][Full Text] [Related]
36. Stabilization and controlled release of bovine serum albumin encapsulated in poly(D, L-lactide) and poly(ethylene glycol) microsphere blends. Jiang W; Schwendeman SP Pharm Res; 2001 Jun; 18(6):878-85. PubMed ID: 11474795 [TBL] [Abstract][Full Text] [Related]
37. Transport of PLA-PEG particles across the nasal mucosa: effect of particle size and PEG coating density. Vila A; Gill H; McCallion O; Alonso MJ J Control Release; 2004 Aug; 98(2):231-44. PubMed ID: 15262415 [TBL] [Abstract][Full Text] [Related]
38. Development and characterisation of chitosan films impregnated with insulin loaded PEG-b-PLA nanoparticles (NPs): a potential approach for buccal delivery of macromolecules. Giovino C; Ayensu I; Tetteh J; Boateng JS Int J Pharm; 2012 May; 428(1-2):143-51. PubMed ID: 22405987 [TBL] [Abstract][Full Text] [Related]
39. Preparation and evaluation of biodegradable films containing the potent osteogenic compound BFB0261 for localized delivery. Umeki N; Sato T; Harada M; Takeda J; Saito S; Iwao Y; Itai S Int J Pharm; 2011 Feb; 404(1-2):10-8. PubMed ID: 21047548 [TBL] [Abstract][Full Text] [Related]
40. Interactions between a macrophage cell line (J774A1) and surface-modified poly (D,L-lactide) nanocapsules bearing poly(ethylene glycol). Mosqueira VC; Legrand P; Gref R; Heurtault B; Appel M; Barratt G J Drug Target; 1999; 7(1):65-78. PubMed ID: 10614816 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]